Andy Cairns - Access to Funding Liverpool SME Workshop
•Download as PPTX, PDF•
1 like•148 views
Presentation by Andy Cairns, Commercial Programme Manager, Innovation Agency
Recommended
Recommended
More Related Content
What's hot
What's hot (20)
Similar to Andy Cairns - Access to Funding Liverpool SME Workshop
Similar to Andy Cairns - Access to Funding Liverpool SME Workshop (20)
More from Innovation Agency
More from Innovation Agency (20)
Recently uploaded
Recently uploaded (20)
Andy Cairns - Access to Funding Liverpool SME Workshop
- 1. Health Innovation Exchange Funding workshop Event 23rd January 2018 @innovationnwc
- 2. Some introductions . . . • Andy and Sue, Innovation Agency • Jason and Sophie, Alder Hey
- 3. Presentation 1 The funding landscape is complex, crowded and confusing
- 4. Some opening remarks • Show of hands if you have submitted a funding bid • Stand up if you have won a funding bid • Put you hand up if securing some funding money is a “nice to have” but not vital to you success • Stand up if securing some funding money is VITAL for your success
- 5. Presentation 1 National and European funding opportunities Andy Cairns
- 6. Role of the AHSN NHS England Government NHS Improvement Partner Contributions, EU funding, industry funding, grants etc Deliver AAR objectives – support local assessment of technologies and knowledge exchange; promote spread of innovation nationally. Translate research into practice and build stronger relationships with the scientific/academic communities and industry to develop solutions to healthcare problems. Deliver Five Year Forward View. Partnerships with academic and research institutions, NHS providers, commissioners, industry. Coordination of the 15 Patient Safety Collaboratives to improve the safety of patients. Role of AHSN Network Proposed future model 2018-2023
- 7. Idea Proof of concept Adoption Spread Innovation and Technology Payment (NHSE) Central reimbursement of innovative products, services and technologies NHS Innovation Accelerator (NHSE) Supporting a small number of fellows to spread their innovations in the NHS Accelerated Access Partnership (OLS) Comprised of cross health economy stakeholders, supporting the development of transformative products, services and technologies via existing routes NHS Apps Library (NHSD) Setting standards for apps looking to be used in the NHS Health Apps Briefing (NICE) Assessment of the economic and efficacy of apps Test Beds (NHSE) Pioneering & evaluating the use of novel combinations of interconnected devices Small Business Research Initiative (NHSE) Provides funding to develop innovative ideas to NHS problems Invention for Innovation (NIHR) Provides funding for development of prototypes There are a number of initiatives supporting the identification and adoption of innovative products, services and technologies OLS NHSE NIHR NICE NHSD
- 8. • Test Beds • SBRI Health • National Innovation Accelerator • Innovation Technology Payment • Accelerated Access Partnership Opportunities for Industry: nationally supported, locally delivered
- 9. SBRI Healthcare is an NHS England funded initiative led by the Academic Health Science Networks to develop technology solutions for known healthcare challenges. 788 jobs created – valued at £47.2m to the UK economy. £140m additional funding leveraged through grants and venture capital. 382 finalised agreements with UK and foreign companies, with more in the pipeline. 135 patents, copyrights, trademarks and scientific publications applied or awarded. Previous competitions included funding for innovations for: • enhanced screening, diagnosis or management of cancer • operational efficiency in acute care • minimising the impact of falling • medical imaging • mental health services for children and adolescents • Up to £100,000 of funding for Phase one (feasibility) and up to £1m for Phase Two (development) • Mental Health & Technology in Surgery Autumn 2017 Now Closed. Register at www.sbrihealthcare.com to receive updates SBRI Health
- 11. • The ITP aims to support the NHS in adopting innovation by removing financial or procurement barriers to uptake of innovative products or technologies. • Competitive process to identify innovations and technologies that will offer the greatest quality and efficiency benefits with wider adoption. • The ITP is looking to support medical devices, digital platforms and technologies. The programme is not suitable for pharmaceutical products or research projects. • select a range of cost effective innovations within budgetary confines • a wide-reaching impact on patient care • maximise learning and foster culture change. • ITP is specifically focused on low cost innovations which can deliver significant patient outcomes and savings to the NHS. • The programme will be delivered in partnership with the AHSNs, sponsors, national and international experts. • Applicants can be from healthcare, academia, commercial or voluntary sectors. • Agreed payment mechanism and procurement will be operational from April 2018. • Day-to-day support and reporting via NHS E’s Innovation and Research Unit. The Innovation and Technology Payment (ITP)
- 12. The Accelerated Access Review recommended that a network of Innovation Exchanges could play a key role in supporting the adoption and uptake of healthcare innovation. • Hosted by AHSNs, Innovation Exchanges will be a central place that stakeholders can go to for information, guidance and support. • Their core functions will include: 1) Identifying need and communicating regional priorities – Help innovators understand what and where are the healthcare demands, and the evidence requirements 2) Signposting – Act as a ‘first port of call for information’ i. Direct innovators to additional support or market access ii. Direct patients towards information about trials and pilots in the region, or new products iii. Offer practical support to commissioners/providers on uptake, collaboration opportunities, dissemination of best practice 3) Validation in a real world setting – Broker regional partnerships with commissioners and providers to offer real world testing opportunities 4) Spread and adoption of innovation across the system – Support scaling up of innovations which are promising on a local level Accelerated Access Partnership
- 13. Speeding up access to innovation The funding is split into four packages. These are: • £39m for the AHSN Network, enabling them to locally assess the benefits of new technologies and support NHS uptake of those that deliver real benefits to patients according to the local need. • A £35m Digital Health Technology Catalyst for innovators – match fund the development of digital technologies for use by patients and the NHS. • Up to £6m over the next 3 years to support SMEs with innovative medicines and devices get the evidence they need by testing in the real world, building on existing opportunities such as the Early Access to Medicine Scheme. • A £6m Pathway Transformation Fund which will help NHS organisations integrate new technologies into everyday practices - help overcome more practical obstacles such as training staff on how to use new equipment.
- 14. Innovate UK Funding The competitions cover the 4 core sector groups, plus the Open programme, with each sector group having 2 competitions in the year. The submission deadlines are: • Strand 1, health and life sciences Opens: January 2018, Closes: 28 March 2018 • advanced therapies (cell and gene therapies) • precision medicine • medicines discovery • advanced biosciences • Emerging and Enabling Technologies – Closes 28 March 2018 • Infrastructure Systems – 31 January 2018 • Manufacturing and Materials – 31 January 2018 • Biomedical Catalyst round4: 7 February 2018
- 15. Presentation 1 Access to EU Finance • Grants, funds and programmes • Loans • Guarantees • Direct funding through grants • Indirect funding through national and local intermediaries
- 16. Presentation 1 Capital/loans and guarantees • Wide range of financing available Entrepreneurs Start-ups Micro businesses SMEs Larger businesses • www.access2finance.eu
- 17. Presentation 1 Indirect / Direct Funding • Indirect Funding 80% - The Big 5 European Structural and Investment Funds • Direct Funding Grants (usually relating to EU policies) ‘Call for Proposals’ Contracts (purchase of goods, services or works) ‘Call for Tender’
- 18. Presentation 1 Executive Agency SMEs (EASME) • COSME • Horizon 2020 https://youtu.be/vpzR6mh8Tv8 • LIFE (Environment and Climate Action) • European Maritime and Fisheries Fund (EMFF) • Intelligent Energy – Europe & Eco-Innovation
- 19. Presentation 1 Innovation in SMEs • Direct financial support Horizon 2020 - SME Instrument • Indirect financial support Enterprise Europe Network
- 20. Presentation 1 SME Instrument • “Ground breaking innovative ideas for products, services or processes that are ready to face global market competition” • “Highly innovative, ambitious, passionate SMEs with global ambition” • €2.5m, world class business coaching and business acceleration services
- 21. Presentation 1 Helpful factors • Actively investing in innovation and looking to grow • Based in an innovation hub • Received grants / VC funding • Received innovation-related tax benefits • Won an innovation prize in the last 2 years
- 22. Presentation 1 Eurostars “R&D Performing SMEs that wish to exploit the benefits that come with international collaboration”
- 23. Presentation 1 Eurostars projects are: • Transnational • Started and led by an SME • Min 3 partners from at least 2 different Eurostars countries • Max 3 years Within two years of completion the product of research should be ready for market introduction
- 24. Presentation 1 Eurostars projects are: • Approved via highly competitive process • Well thought of with strong partnerships and excellent business ideas • Successful in terms of attracting private investment Budget has increased from €100m (2008-2014) to €287m (2014-2020)
- 25. Presentation 1 • World’s largest business network • 600 organisations to find and connect partners • Funded in the UK by the European Commission and Innovate UK • Local organisation is RTC North at Sci-Tech Daresbury
- 26. • A Knowledge and Innovation Community within the European Institute of Innovation and Technology • 140 partners from across Europe • promotes healthy living, active ageing and improvements in healthcare • Opportunities for SMEs – two local SMEs received €50,000 towards commercial development
- 29. Closing remarks . . . • Keep a track of all the pots and we will as well • Be honest and realistic when considering eligibility criteria • Any bid submission needs to be compelling • Your pitch to the panel needs to be persuasive • We are here to help with editing, but cant be the author! • Next meetings – March Positioning, presenting and pitching you and your product/solution
- 31. Thank you! • Andy Cairns 07507 847 345 andrew.cairns@innovationagencynwc.nhs. uk • Jason Taylor 07764 439 306 Jason.P.Taylor@alderhey.nhs.uk
Editor's Notes
- Culture Raising awareness of the impact culture has on safety, helping to create the conditions to enable health care organisations to nurture and develop a culture of safety Deterioration Reducing avoidable harm and enhance the outcomes and experience of patients who are deteriorating across England through improved recognition, response and communication and the use of early warning systems Maternal and neonatal Supporting the national Maternal and Neonatal Health Safety Collaborative, working to develop and deliver local improvement plans and creating a national maternal and neonatal learning system through communities of practice.
- Any size of business is eligible Other organisations are eligible as long as the route to market is demonstrated All contract values quoted include VAT Applications assessed on Fair Market Value Contract terms are non-negotiable Single applicant (partners shown as sub contractors) Applicants must fully complete the application form Helping the Public Sector address challenges Using innovation to achieve a step change Accelerating technology commercialisation Providing a route to market Support and the development of Innovative companies Providing a lead customer/R&D partner Providing funding and credibility for fund raising 100% funded R&D Operate under procurement rules rather than state aid rules UK implementation of EU Pre-Commercial Procurement Deliverable based rather than hours worked or costs incurred Contract with Prime Supplier Who may choose to sub contract but remains accountable IP rests with Supplier Certain usage rights with Public Sector – Companies encouraged to exploit IP Light touch Reporting & payments quarterly & up front
- Damibu Dave Burrows and ORCHA Liz Ashall-Payne
- ITT Innovation Technology Tariff already in place 6 plus AF Urolift NIC Non Injectable arterial connector Episcissors PneuX FCT not available myCOPD AF
- The early access to medicines scheme (EAMS) aims to give patients with life threatening or seriously debilitating conditions access to medicines that do not yet have a marketing authorisation when there is a clear unmet medical need. Under the scheme, the Medicines and Healthcare products Regulatory Agency (MHRA) will give a scientific opinion on the benefit/risk balance of the medicine, based on the data available when the EAMS submission was made.
- Examples of finance available from EU 2 copies printed out
- The 5 funds 2014 - 2020 The European structural and investment funds are: European regional development fund (ERDF) – promotes balanced development in the different regions of the EU. European regional development fund (ERDF) European social fund (ESF) - supports employment-related projects throughout Europe and invests in Europe’s human capital – its workers, its young people and all those seeking a job. European social fund (ESF) Cohesion fund (CF) – funds transport and environment projects in countries where the gross national income (GNI) per inhabitant is less than 90% of the EU average. In 2014-20, these are Bulgaria, Croatia, Cyprus, the Czech Republic, Estonia, Greece, Hungary, Latvia, Lithuania, Malta, Poland, Portugal, Romania, Slovakia and Slovenia. Cohesion fund (CF) European agricultural fund for rural development (EAFRD) – focuses on resolving the particular challenges facing EU's rural areas. European agricultural fund for rural development (EAFRD) European maritime and fisheries fund (EMFF) – helps fishermen to adopt sustainable fishing practices and coastal communities to diversify their economies, improving quality of life along European coasts. European maritime and fisheries fund (EMFF)
- COSME is the EU programme for the Competitiveness of Enterprises and SMEs, running from 2014 to 2020, with a budget of €2.3billion. COSME will support SMEs in the following areas: •Facilitating access to finance • Supporting internationalisation and access to markets • Creating an environment favourable to competitiveness • Encouraging an entrepreneurial culture On 27 October 2017, the European Commission presented the final Work Programme for Horizon 2020, covering the budgetary years 2018, 2019 and 2020 and representing an investment of around €30 billion.
- Small and Medium-sized Enterprises that are EU-based or established in a country associated to Horizon 2020 can now get EU funding and support for breakthrough innovation projects with a market-creating potential under revamped SME instrument, which is rolled out as part of the European Innovation Council (EIC) pilot. The SME instrument will boost fast company growth and market-creating innovation thanks to staged funding and ramped up business acceleration services The SME instrument is part of the European Innovation Council pilot (EIC pilot). This was launched on 27th October 2017 as part of the Horizon 2020 Work programme 2018-2020, when the SME Instrument, the Fast Track to Innovation(FTI), Future and Emerging Technologies (FET) Open and Horizon Prizes, were brought under the EIC pilot umbrella, to provide a 'one stop shop' for funding of innovators/innovations in the EU. What support is available? The SME instrument supports close-to-market activities, with the aim to give a strong boost to breakthrough innovation with a market-creating potential. Highly innovative SMEs with a clear commercial ambition and a potential for high growth and internationalisation are the prime target. The SME Instrument offers small and medium-sized businesses the following: Business innovation grants for feasibility assessment purposes (optional phase I): EUR 50,000 (lump sum) per project (70% of total cost of the project); Business innovation grants for innovation development & demonstration purposes (possible phase II): an amount in the indicative range of EUR 500,000 and 2,5 million (70% of total cost of the project as a general rule); Free-of-charge business coaching (optional) in order to support and enhance the firm’s innovation capacity and help align the project to strategic business needs; Access to a wide range of other business acceleration services and facilitated access to risk finance, to facilitate the commercial exploitation of the innovation.
- In the UK, only research-performing SME's are eligible for funding under Eurostars. Academics/universities and large companies are welcome to participate in a Eurostars project, but must fund their own participation or use funds from other sources. The Technology Strategy Board will fund either 360,000 euros or 60% of the eligible projects costs, whichever is the least, per UK partner in a Eurostars project. SMEs must have been registered as a UK company for 12 months, have PAYE staff and been trading for 12 months prior to application. All costs must be incured in the UK and all work must be carried out in the UK. There are specific accountancy rules for Sole Traders and Micro Companies. For more details on UK eligibility costs and funding please read the UK Eligibility Criteria Eurostars 2018 call.
- RTC North originated as the Regional Technology Centre (RTC) RTC North is one of Europe’s leading technology transfer companies which has built its reputation over the past 25 years on managing large public sector contracts as well as delivering discrete consultancy projects to industry, research institutes and the higher education sector. RTC North’s status as an independent technology transfer company, sponsored by several world-class companies and research institutes and accredited by the EU is quite unique. In addition, the organisation has an unrivalled network of European contacts. The Company has had vast experience of helping organisations with all stages of the innovation and IP commercialisation process and is an active member of key European innovation and technology transfer networks such as Enterprise Europe Network and the Association of European Technology Transfer Professionals (Tii) More specifically, we have been members of various European technology and business Networks since the days of the Value Relay Centres in 1993 and more recently the IRC network. We are the regional lead for EEN in Northern England and have offices in three regions: North East (Sunderland), Yorkshire and the Humber (Leeds) and North West (Daresbury). If you are unsure of the UK geography or the roles of our partners in the North, please contact the Sunderland head office and we will find you the correct contact +44 191 5164400, or call the consortium's National Enquiry Gateway +44 300 123 3144. . Address Daresbury Innovation Centre, Keckwick Lane WA4 4FS Daresbury United Kingdom enquiries@rtcnorth.co.uk +44 1925607040 http:www.rtcnorth.co.uk
- Damibu and now Morow EIT European Institute of Innovation and Technology What we do: We work to give EU citizens greater opportunities to enjoy a healthier and active life for longer, and to postpone dependency on others, by leveraging big data and new technologies, identifying and removing barriers to innovation, and building on education and talent creation.
- Biotechnology and Biological Sciences Research Council (BBSRC) Engineering and physical Sciences Research council Medical Research Council
- Health Foundation
- Horizon Scanning •121 Surgeries •Application Check •Application Drafting –rare!